Author(s): Sakshi Nand, Neelabh

Email(s): srivastava.neelabh@gmail.com

DOI: 10.52711/2231-5691.2021.00031   

Address: Sakshi Nand, Neelabh
Department of Biotechnology, SR Institute of Management and Technology, Lucknow – 226201.
*Corresponding Author

Published In:   Volume - 11,      Issue - 3,     Year - 2021


ABSTRACT:
Introduction: Since Covid-19 has emerged as a pandemic, it has taken innumerable lives and caused havoc in the developing as well as developed countries. The health facilities throughout the world have taken a toll and to counter this some immediate alternative measures have to be taken. Utilization of the plant-based products from the Indian traditional medicine can be one such measure. Methods: NCBI, Pubchem and PDB databases were used to obtain the structures of the relevant protein targets and plant-based ligands. Apart from this, softwares such as Open Babel, UCSF Chimera, PatchDock and FireDock were used for the purpose of interconversion of file formats, visualization of the structures and docking respectively. Results: After the screening of 9 plant-based products against the 3 main protein targets (spike protein, hemagglutinin, nucleocapsid) of corona virus we found that glucoraphanin showed the best binding energy against spike protein (-51.44 KJ/mol), alpha amyrin showed the best binding energy against hemagglutinin (-31.76 KJ/mol) and beta-sitosterol showed best binding energy against nucleocapsid (-55.44 KJ/mol). Conclusion: This study would aid in the speedy recovery and better immune response of the corona virus infected patients.


Cite this article:
Sakshi Nand, Neelabh. Therapeutic effect of certain Indian medicinal compounds against the Corona Virus: An in-silico study. Asian Journal of Pharmaceutical Research. 2021; 11(3):167-2. doi: 10.52711/2231-5691.2021.00031

Cite(Electronic):
Sakshi Nand, Neelabh. Therapeutic effect of certain Indian medicinal compounds against the Corona Virus: An in-silico study. Asian Journal of Pharmaceutical Research. 2021; 11(3):167-2. doi: 10.52711/2231-5691.2021.00031   Available on: https://www.asianjpr.com/AbstractView.aspx?PID=2021-11-3-5


REFERENCES:
1.    Wollina, U. (2020). Challenges of COVID‐19 pandemic for dermatology. Dermatologic therapy, 33(5), e13430.
2.    Singh, K. (2021). In-silico studies of some natural, synthetic and semi-synthetic antifungal drugs for their multi-targeting nature. Journal of Microbiology, Biotechnology and Food Sciences, 2021, 711-716.
3.    Gautret, P., Million, M., Jarrot, P. A., Camoin-Jau, L., Colson, P., Fenollar, F. and Raoult, D. (2020). Natural history of COVID-19 and therapeutic options. Expert Review of Clinical Immunology, 1-24.
4.    Fini, M. B. (2020). What dentists need to know about COVID-19. Oral oncology, 104741.
5.    Kahn, J. S., and McIntosh, K. (2005). History and recent advances in coronavirus discovery. The Pediatric infectious disease journal, 24(11), S223-S227.
6.    Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, Ma H, Chen W, Lin Y, Zheng Y, Wang J, Hu Z, Yi Y, Shen H Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing. Sci China Life Sci. 2020 May; 63(5): 706-711. doi: 10.1007/s11427-020-1661-4. Epub 2020 Mar 4. PMID: 32146694.
7.    Ramesh, S. (2021). ‘Double mutant, triple mutant, Bengal lineage’ — Covid variants driving India surge decoded. ThePrint. Accessed on 26th April, 2021 from https://theprint.in/science/double-mutant-triple-mutant-bengal-lineage-covid-variants-driving-india-surge-decoded/643766/
8.    Payne, S. (2017). Family Coronaviridae. Viruses, Elsevier Public Health Emergency Collection 149-158.
9.    Narayanasamy A, Narayanasamy M. Ayurvedic medicine: An introduction for nurses, Br J Nurs. 2006 Nov 23-Dec 13;15(21):1185-90. doi: 10.12968/bjon.2006.15.21.22378.PMID: 17170694.
10.    Rajkumar RP Ayurveda and COVID-19: Where psychoneuroimmunology and the meaning response meet, Brain Behav Immun. 2020 Jul;87:8-9. doi: 10.1016/j.bbi.2020.04.056. Epub 2020 Apr 22.PMID: 32334064.
11.    Poolsup, N., Suksomboon, N., and Paw, N. J. (2017). Effect of dragon fruit on glycemic control in prediabetes and type 2 diabetes: A systematic review and meta-analysis. Plos one, 12(9), e0184577.
12.    Singh, N., Bhalla, M., de Jager, P., and Gilca, M. (2011). An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. African Journal of Traditional, Complementary and Alternative Medicines, 8(5S).
13.    Amenta, M., Ballistreri, G., Fabroni, S., Romeo, F. V., Spina, A., and Rapisarda, P. (2015). Qualitative and nutraceutical aspects of lemon fruits grown on the mountainsides of the Mount Etna: A first step for a protected designation of origin or protected geographical indication application of the brand name ‘Limone dell'Etna’. Food Research International, 74, 250-259.
14.    Macoy, D. M., Kim, W. Y., Lee, S. Y., and Kim, M. G. (2015). Biosynthesis, physiology, and functions of hydroxycinnamic acid amides in plants. Plant Biotechnology Reports, 9(5), 269-278.
15.    Srinagesh, J., Krishnappa, P., and Somanna, S. (2012). Antibacterial efficacy of triphala against oral streptococci: An in vivo study. Indian Journal of Dental Research, 23(5), 696.
16.    Younus, I., Siddiq, A., Ishaq, H., Anwer, L., Badar, S., and Ashraf, M. (2016). Evaluation of antiviral activity of plant extracts against foot and mouth disease virus in vitro. Pak. J. Pharm. Sci, 29(4), 1263-1268.
17.    Qian, S., Fan, W., Qian, P., Zhang, D., Wei, Y., Chen, H., and Li, X. (2015). Apigenin restricts FMDV infection and inhibits viral IRES driven translational activity. Viruses, 7(4), 1613-1626.
18.    Shen, S., Tan, T. H., and Tan, Y. J. (2007). Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV. Glycovirology Protocols, 127-135.
19.    Cascarina, S. M., and Ross, E. D. (2020). A proposed role for the SARS‐CoV‐2 nucleocapsid protein in the formation and regulation of biomolecular condensates. The FASEB Journal, 34(8), 9832-9842.
20.    Zeng, Q., Langereis, M. A., Van Vliet, A. L., Huizinga, E. G., and De Groot, R. J. (2008). Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution. Proceedings of the National Academy of Sciences, 105(26), 9065-9069.
21.    O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., and Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of cheminformatics, 3(1), 1-14.
22.    Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., and Ferrin, T. E. (2004). UCSF Chimera—a visualization system for exploratory research and analysis. Journal of computational chemistry, 25(13), 1605-1612.
23.    Mashiach, E., Schneidman-Duhovny, D., Andrusier, N., Nussinov, R., and Wolfson, H. J. (2008). FireDock: a web server for fast interaction refinement in molecular docking. Nucleic acids research, 36(suppl_2), W229-W232.
24.    Yadav, N. (2021). These are the 10 most-affected countries with the highest number of COVID-19 cases, Business Insider India, Accessed on 03 May, 2021 from https://www.businessinsider.in/politics/india/news/check-out-the-10-most-affected-countries-with-the-highest-number-of-coronavirus-cases/slidelist/76275918.cms
25.    Pandey, V., and Nazmi, S. (2021) Covid-19 in India: Why second coronavirus wave is devastating, BBC News, Accessed on 05 May, 2021 from https://www.bbc.com/news/world-asia-india-56811315
26.    Puttaswamy, H., Gowtham, H. G., Ojha, M. D., Yadav, A., Choudhir, G., Raguraman, V., ... and Chauhan, L. (2020). In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis. Scientific reports, 10(1), 1-24.
27.    Rivero-Segura, N. A., and Gomez-Verjan, J. C. (2021). In Silico Screening of Natural Products Isolated from Mexican Herbal Medicines against COVID-19. Biomolecules, 11(2), 216.
28.    -Ananth, R. P., Rana, A., Rajan, N., Biswal, H. S., and Samal, A. (2020). In silico identification of potential natural product inhibitors of human proteases key to SARS-CoV-2 infection. Molecules, 25(17), 3822.
29.    Alrasheid, A. A., Babiker, M. Y., and Awad, T. A. (2021). Evaluation of certain medicinal plants compounds as new potential inhibitors of novel corona virus (COVID-19) using molecular docking analysis. In Silico Pharmacology, 9(1), 1-7.

Recomonded Articles:

Author(s): Dhanashri Aware, Sachin Rohane

DOI: 10.52711/2231-5691.2021.00037         Access: Open Access Read More

Author(s): Manisha Rokade, Pradnya Khandagale

DOI: 10.5958/2231-5691.2020.00042.8         Access: Open Access Read More

Author(s): Ravindra Gaikwad, Sanket Rathod, Anilkumar Shinde

DOI: 10.52711/2231-5691.2022.00043         Access: Open Access Read More

Author(s): Swati G. Talele, Eknath D. Ahire, Khemchand R. Surana, Vijayraj N. Sonawane, Gokul S. Talele

DOI: 10.52711/2231-5691.2022.00008         Access: Open Access Read More

Author(s): Kandra Naga Vishnu, Praveen Kumar Uppala, Yakaiah Vangoori, Siva Naga Koteswara Rao Gudhanti

DOI: 10.52711/2231-5691.2021.00042         Access: Open Access Read More

Author(s): Ashwini P. Dhruv, Nilesh K. Patel, Ashok B. Patel, Amit Kumar J. Vyas, Ajay I. PatelAshwini P. Dhruv, Nilesh K. Patel, Ashok B. Patel, Amit Kumar J. Vyas, Ajay I. Patel

DOI: 10.52711/2231-5691.2022.00036         Access: Open Access Read More

Author(s): Isha Sharma, Neha Sharma, Michi Moda, Mansi Thakur, Kriti Sharma

DOI: 10.52711/2231-5691.2023.00052         Access: Open Access Read More

Author(s): D. Sunitha, M. Sudhakar

DOI: 10.52711/2231-5691.2023.00021         Access: Open Access Read More

Author(s): Manjusha S. Kareppa, Priti B. Savant, Shachi V. Ratnaparkhi, Sohel S. Shaikh, Mohini B. Kadbhane, Someshwar M. Naybal

DOI: 10.52711/2231-5691.2023.00024         Access: Open Access Read More

Author(s): Esha Yadav, Sagar Singh, Pratima Kumari, Sachin Singh Rathore, Khushi Gupta, Vaishali

DOI: 10.52711/2231-5691.2024.00039         Access: Closed Access Read More


Recent Articles




Tags